National Institutes of Health

Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.

Mount Sinai Health System is an integrated healthcare system based in New York, providing exceptional medical care to local and global communities. Established in 2013 through the merger of Mount Sinai Medical Center and Continuum Health Partners, it encompasses the Icahn School of Medicine and operates seven hospital campuses throughout the New York metropolitan area. The system is recognized for its excellence in research, patient care, and education across various specialties. It features a vast network of over 7,000 primary and specialty care physicians, as well as more than 45 ambulatory practices and 12 minority-owned free-standing ambulatory surgery centers. Mount Sinai is committed to improving healthcare quality and accessibility, focusing on compassionate patient experiences and the development of strong relationships between staff and patients. Additionally, its venture capital arm, Mount Sinai Ventures, invests in healthcare startups, further enhancing its capacity to innovate and respond to the diverse health needs of the populations it serves.

Behaivior LLC is a digital health company based in Pittsburgh, Pennsylvania, focused on predicting and preventing addiction relapses through innovative technology. Founded in 2017, Behaivior integrates wearable devices with machine learning algorithms to analyze real-time data from various physiological metrics, such as heart rate and skin temperature. The company’s platform, known as Recovery, employs this data to deliver timely interventions tailored to the needs of individuals in recovery. By utilizing a SaaS business model, Behaivior aims to democratize mental health recovery and support, assisting users in maintaining their wellness while enabling care providers to enhance their service delivery. Through its proactive approach, Behaivior seeks to improve mental health outcomes and reduce crisis events associated with addiction.

BetterAge is a company dedicated to enhancing the health and well-being of older adults through innovative technology solutions. Founded on the principle that all adults can age well regardless of their current circumstances, BetterAge has developed a digital platform designed exclusively for this demographic. The platform provides personalized, objective content tailored to the needs of older adults, offering education and information about disease risks and actionable insights to support informed decision-making. By fostering a network of experts in aging services, health, and technology, BetterAge aims to create thriving communities where older adults can lead active and healthy lives.

Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.

Behaivior LLC is a digital health company based in Pittsburgh, Pennsylvania, focused on predicting and preventing addiction relapses through innovative technology. Founded in 2017, Behaivior integrates wearable devices with machine learning algorithms to analyze real-time data from various physiological metrics, such as heart rate and skin temperature. The company’s platform, known as Recovery, employs this data to deliver timely interventions tailored to the needs of individuals in recovery. By utilizing a SaaS business model, Behaivior aims to democratize mental health recovery and support, assisting users in maintaining their wellness while enabling care providers to enhance their service delivery. Through its proactive approach, Behaivior seeks to improve mental health outcomes and reduce crisis events associated with addiction.

Is my medication working? Levl helps you reveal the answer. Levl measures the effectiveness of medications and offers insights to get the most out of mental health treatments. Levl helps people stick to their treatment while supporting clinicians in optimizing the medication.

Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.

RAE Health is a mental health solutions company focused on addressing substance use disorders through innovative technology. It develops monitoring tools designed to empower patients and support healthcare providers by facilitating timely interventions. The company's technology identifies, detects, and tracks patterns related to cravings, stress, and drug use. By leveraging this data, RAE Health aims to enhance patient engagement and improve outcomes, ultimately contributing to the reduction of relapse rates and saving lives.

Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.

Aural Analytics, Inc. is a Scottsdale, Arizona-based company founded in 2015 that specializes in brain health monitoring through innovative technology. The company has developed a multi-modal analytics platform that utilizes artificial intelligence, signal processing, and speech analytics to detect subtle changes in neurological health. By converting smartphones and tablets into effective brain health monitors, Aural Analytics enables the collection of objective and interpretable data. This technology supplements traditional functional rating scales used in clinical trials, providing continuous and reliable metrics for assessing the effectiveness of medical interventions. Aural Analytics' platform captures clinically relevant speech, fine motor, and linguistic samples to offer healthcare professionals accurate assessments of patient health, thereby enhancing the understanding of disease progression.

Modality.AI, Inc. is a healthcare technology company based in San Francisco, California, founded in 2018. It specializes in AI-powered solutions that enhance the efficiency of clinical trials for neurological and mental health therapies. The company's platform utilizes conversational AI to engage patients through naturalistic spoken interaction, allowing for continuous health assessments anytime and anywhere. By analyzing multimodal data, including audio-visual biomarkers, Modality.AI provides objective measures that correlate with clinical outcomes. This innovative approach enables pharmaceutical companies to conduct self-driven assessments and improve the monitoring of health conditions, ultimately facilitating more effective clinical trials.

Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.

Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.

Neurotype develops a neurofeedback-based medical platform aimed at supporting recovery from substance use disorders. Its NeuromarkR system, comprising a headset and software, measures brain signatures of drug cravings triggered by environmental cues. This enables clinicians to quantify craving risks and guide targeted interventions using Cognitive Behavioral Therapy (CBT) and Mindfulness-Based Treatment (MBT) strategies.

Lohocla Research is a research and development company focused on the discovery and development of medications for chronic pain, addiction, and various mental health and neurological disorders. It operates a specialized bioscience center dedicated to pre-clinical and early-stage clinical trials. Unlike many pharmaceutical companies, Lohocla prioritizes the development of biological markers that assist physicians in prescribing its medications to the most appropriate patients. This commitment to personalized medicine underpins its research initiatives, ensuring tailored treatment options that align with individual patient needs.

Behaivior LLC is a digital health company based in Pittsburgh, Pennsylvania, focused on predicting and preventing addiction relapses through innovative technology. Founded in 2017, Behaivior integrates wearable devices with machine learning algorithms to analyze real-time data from various physiological metrics, such as heart rate and skin temperature. The company’s platform, known as Recovery, employs this data to deliver timely interventions tailored to the needs of individuals in recovery. By utilizing a SaaS business model, Behaivior aims to democratize mental health recovery and support, assisting users in maintaining their wellness while enabling care providers to enhance their service delivery. Through its proactive approach, Behaivior seeks to improve mental health outcomes and reduce crisis events associated with addiction.

HealthRhythms develops a digital platform that assesses and monitors mental health conditions using deep machine learning and predictive analytics. Its solution offers real-time behavioral monitoring and personalized interventions, enabling healthcare providers to accurately measure mental health status and deliver timely care.

Health Behavior Solutions exists to break down the barriers to getting evidence-based mental health treatments. Our goal is to empower individuals to manage living with depression through the use of digital health technology augmented with health and wellness coaching. We are building products that actively engage people, while helping them make positive life changes that are readily integrated into their daily routines.

Health Behavior Solutions exists to break down the barriers to getting evidence-based mental health treatments. Our goal is to empower individuals to manage living with depression through the use of digital health technology augmented with health and wellness coaching. We are building products that actively engage people, while helping them make positive life changes that are readily integrated into their daily routines.

Health Behavior Solutions exists to break down the barriers to getting evidence-based mental health treatments. Our goal is to empower individuals to manage living with depression through the use of digital health technology augmented with health and wellness coaching. We are building products that actively engage people, while helping them make positive life changes that are readily integrated into their daily routines.

Health Behavior Solutions exists to break down the barriers to getting evidence-based mental health treatments. Our goal is to empower individuals to manage living with depression through the use of digital health technology augmented with health and wellness coaching. We are building products that actively engage people, while helping them make positive life changes that are readily integrated into their daily routines.

Lohocla Research is a research and development company focused on the discovery and development of medications for chronic pain, addiction, and various mental health and neurological disorders. It operates a specialized bioscience center dedicated to pre-clinical and early-stage clinical trials. Unlike many pharmaceutical companies, Lohocla prioritizes the development of biological markers that assist physicians in prescribing its medications to the most appropriate patients. This commitment to personalized medicine underpins its research initiatives, ensuring tailored treatment options that align with individual patient needs.

Provata Health is a pioneering company in the field of digital preventive medicine, recognized for creating a digital health platform that has demonstrated significant physical and mental health benefits in peer-reviewed studies. The platform is designed to enhance employee health and wellness through a variety of innovative features, including digital health games, virtual reality meditation, and health coaching. By providing real-time access to a network of over 80,000 licensed physicians in the United States, Provata facilitates comprehensive care management. Additionally, the platform incorporates advanced activity tracking and integrates data from various providers, laboratories, pharmacies, and devices. This holistic approach helps organizations reduce healthcare costs while engaging employees and fostering a healthier workforce. Celebrated by numerous media outlets for its transformative impact, Provata Health is at the forefront of the digital health revolution.

Founded in 2006, Promentis Pharmaceuticals is a biopharmaceutical company based in Milwaukee, Wisconsin. It develops therapies targeting the central nervous system for treating neuropsychiatric disorders such as impulse control disorders and obsessive-compulsive disorder.